1. Home
  2. BELFB vs DYN Comparison

BELFB vs DYN Comparison

Compare BELFB & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bel Fuse Inc. Class B

BELFB

Bel Fuse Inc. Class B

HOLD

Current Price

$153.36

Market Cap

1.8B

Sector

N/A

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$22.25

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BELFB
DYN
Founded
1949
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BELFB
DYN
Price
$153.36
$22.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
15
Target Price
$153.75
$36.53
AVG Volume (30 Days)
186.0K
2.6M
Earning Date
10-29-2025
11-05-2025
Dividend Yield
0.18%
N/A
EPS Growth
19.52
N/A
EPS
5.17
N/A
Revenue
$649,376,000.00
N/A
Revenue This Year
$26.78
N/A
Revenue Next Year
$6.19
N/A
P/E Ratio
$29.84
N/A
Revenue Growth
23.70
N/A
52 Week Low
$58.00
$6.36
52 Week High
$167.04
$31.29

Technical Indicators

Market Signals
Indicator
BELFB
DYN
Relative Strength Index (RSI) 53.49 61.55
Support Level $133.71 $20.44
Resistance Level $152.26 $22.27
Average True Range (ATR) 8.42 1.50
MACD 0.05 -0.00
Stochastic Oscillator 56.56 98.32

Price Performance

Historical Comparison
BELFB
DYN

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: